PURPOSE: Catheter ablation of atrial fibrillation (AF) in patients with hypertrophic cardiomyopathy (HCM) is still challenging, and it is unclear whether the difficulty is caused by the hypertrophy of left atrial (LA) myocardial wall thickness. The objective of the study was to compare the LA wall thickness and AF ablation outcomes between patients with HCM and those without structural heart disease. METHODS: The present study enrolled 17 consecutive HCM patients (63 ± 12 years) with drug-refractory AF and 34 control patients without any detectable heart disease, whose age, gender, type of AF, and LA dimension were matched to the HCM patients. The myocardial wall thickness of 11 distinct LA locations, measured using 64-slice computed tomography images, and AF ablation outcomes were compared between the two groups. RESULTS: The LA wall thickness did not differ at 9 of the 11 locations and was significantly thinner in the HCM patients than in the control patients at the mid-posterior wall (1.44 ± 0.17 vs. 1.58 ± 0.22, p = 0.04) and infero-posterior wall (1.62 ± 0.16 vs. 1.74 ± 0.18, p = 0.03). Although antiarrhythmic drugs were used more frequently in the HCM patients (p = 0.008), the rate of maintaining sinus rhythm during the follow-up did not differ between the HCM and control patients (53 vs. 56% after the initial ablation [log-rank p = 0.78] and 82 and 88% after the repeat procedure [log-rank p = 0.35]). CONCLUSIONS: The LA wall in the HCM patients with AF was not thicker than that of the matched patients without structural heart disease. Catheter ablation of AF showed favorable outcomes in both patient groups.
PURPOSE: Catheter ablation of atrial fibrillation (AF) in patients with hypertrophic cardiomyopathy (HCM) is still challenging, and it is unclear whether the difficulty is caused by the hypertrophy of left atrial (LA) myocardial wall thickness. The objective of the study was to compare the LA wall thickness and AF ablation outcomes between patients with HCM and those without structural heart disease. METHODS: The present study enrolled 17 consecutive HCM patients (63 ± 12 years) with drug-refractory AF and 34 control patients without any detectable heart disease, whose age, gender, type of AF, and LA dimension were matched to the HCM patients. The myocardial wall thickness of 11 distinct LA locations, measured using 64-slice computed tomography images, and AF ablation outcomes were compared between the two groups. RESULTS: The LA wall thickness did not differ at 9 of the 11 locations and was significantly thinner in the HCM patients than in the control patients at the mid-posterior wall (1.44 ± 0.17 vs. 1.58 ± 0.22, p = 0.04) and infero-posterior wall (1.62 ± 0.16 vs. 1.74 ± 0.18, p = 0.03). Although antiarrhythmic drugs were used more frequently in the HCM patients (p = 0.008), the rate of maintaining sinus rhythm during the follow-up did not differ between the HCM and control patients (53 vs. 56% after the initial ablation [log-rank p = 0.78] and 82 and 88% after the repeat procedure [log-rank p = 0.35]). CONCLUSIONS: The LA wall in the HCM patients with AF was not thicker than that of the matched patients without structural heart disease. Catheter ablation of AF showed favorable outcomes in both patient groups.
Authors: Fethi Kilicaslan; Atul Verma; Eduardo Saad; Sakis Themistoclakis; Aldo Bonso; Antonio Raviele; Huseyin Bozbas; Michelle Williams Andrews; Salwa Beheiry; Steven Hao; Jennifer E Cummings; Nassir F Marrouche; Dhannunjaya Lakkireddy; Oussama Wazni; Hirosuke Yamaji; Luis C Saenz; Walid Saliba; Robert A Schweikert; Andrea Natale Journal: Heart Rhythm Date: 2006-03 Impact factor: 6.343
Authors: T Jared Bunch; Thomas M Munger; Paul A Friedman; Samuel J Asirvatham; Peter A Brady; Yong-Mei Cha; Robert F Rea; Win-Kuang Shen; Brian D Powell; Steve R Ommen; Kristi H Monahan; Janis M Haroldson; Douglas L Packer Journal: J Cardiovasc Electrophysiol Date: 2008-05-09
Authors: Barry J Maron; Iacopo Olivotto; Pietro Bellone; Maria Rosa Conte; Franco Cecchi; Björn P Flygenring; Susan A Casey; Thomas E Gohman; Sergio Bongioanni; Paolo Spirito Journal: J Am Coll Cardiol Date: 2002-01-16 Impact factor: 24.094
Authors: John Whitaker; Ronak Rajani; Henry Chubb; Mark Gabrawi; Marta Varela; Matthew Wright; Steven Niederer; Mark D O'Neill Journal: Europace Date: 2016-05-31 Impact factor: 5.214
Authors: Melinda Boussoussou; Bálint Szilveszter; Borbála Vattay; Márton Kolossváry; Milán Vecsey-Nagy; Zoltán Salló; Gábor Orbán; Perge Péter; Piros Katalin; Nagy Klaudia Vivien; Osztheimer István; Pál Maurovich-Horvat; Béla Merkely; László Gellér; Nándor Szegedi Journal: Int J Cardiovasc Imaging Date: 2022-02-09 Impact factor: 2.357
Authors: Travis J Moss; Matthew M Zipse; Mori J Krantz; William H Sauer; Ernesto E Salcedo; Joseph L Schuller Journal: Ann Noninvasive Electrocardiol Date: 2016-03-11 Impact factor: 1.468
Authors: Hakeem S K Ha; Nelson Wang; Sophia Wong; Steven Phan; Jace Liao; Narendra Kumar; Pierre Qian; Tristan D Yan; Kevin Phan Journal: J Interv Card Electrophysiol Date: 2015-08-25 Impact factor: 1.900
Authors: Rashed Karim; Lauren-Emma Blake; Jiro Inoue; Qian Tao; Shuman Jia; R James Housden; Pranav Bhagirath; Jean-Luc Duval; Marta Varela; Jonathan M Behar; Loïc Cadour; Rob J van der Geest; Hubert Cochet; Maria Drangova; Maxime Sermesant; Reza Razavi; Oleg Aslanidi; Ronak Rajani; Kawal Rhode Journal: Med Image Anal Date: 2018-08-24 Impact factor: 8.545
Authors: John Whitaker; Júlia Karády; Rashed Karim; Catalina Tobon-Gomez; Thomas Fastl; Orod Razeghi; Louisa O'Neill; Marie Decroocq; Steven Williams; Cesare Corrado; Rahul K Mukherjee; Iain Sim; Daniel O'Hare; Irum Kotadia; Márton Kolossváry; Bela Merkely; Levente Littvay; Adam D Tarnoki; David L Tarnoki; Szilard Voros; Reza Razavi; Mark O'Neill; Ronak Rajani; Pál Maurovich Horvat; Steven Niederer Journal: Int J Cardiol Heart Vasc Date: 2020-12-24